· Periodic Report
Q3 operating loss of KRW 6.3 billion, turning to a loss; sales of KRW 136.7 billion
Jeil Pharmaceutical sold KRW 136.7 billion in Q3 but lost KRW 6.3 billion from its main business, down from a profit a year earlier.
271980 · KOSPI · Based on DART filings
1 total · 20 per page
· Periodic Report
Jeil Pharmaceutical sold KRW 136.7 billion in Q3 but lost KRW 6.3 billion from its main business, down from a profit a year earlier.
Get app alerts for new disclosures from JEIL PHARMACEUTICAL CO.,LTD.